These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 38593870)
1. Targeting inhibitory Siglec-3 to suppress IgE-mediated human basophil degranulation. Barshow SM; Islam M; Commins S; Macauley MS; Paulson JC; Kulis MD J Allergy Clin Immunol; 2024 Aug; 154(2):492-497.e1. PubMed ID: 38593870 [TBL] [Abstract][Full Text] [Related]
2. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb. Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161 [TBL] [Abstract][Full Text] [Related]
3. Non-Digestible Oligosaccharides Can Suppress Basophil Degranulation in Whole Blood of Peanut-Allergic Patients. Hayen SM; den Hartog Jager CF; Knulst AC; Knol EF; Garssen J; Willemsen LEM; Otten HG Front Immunol; 2018; 9():1265. PubMed ID: 29942305 [TBL] [Abstract][Full Text] [Related]
4. Combining avidin with CD63 improves basophil activation test accuracy in classifying peanut allergy. Castaño N; Chua K; Kaushik A; Kim S; Cordts SC; Nafarzadegan CD; Hofmann GH; Seastedt H; Schuetz JP; Dunham D; Parsons ES; Tsai M; Cao S; Desai M; Sindher SB; Chinthrajah RS; Galli SJ; Nadeau KC; Tang SKY Allergy; 2024 Feb; 79(2):445-455. PubMed ID: 37916710 [TBL] [Abstract][Full Text] [Related]
5. Food allergy herbal formula 2 protection against peanut anaphylactic reaction is via inhibition of mast cells and basophils. Song Y; Qu C; Srivastava K; Yang N; Busse P; Zhao W; Li XM J Allergy Clin Immunol; 2010 Dec; 126(6):1208-17.e3. PubMed ID: 21134573 [TBL] [Abstract][Full Text] [Related]
6. Novel peanut-specific human IgE monoclonal antibodies enable screens for inhibitors of the effector phase in food allergy. Suber J; Zhang Y; Ye P; Guo R; Burks AW; Kulis MD; Smith SA; Iweala OI Front Immunol; 2022; 13():974374. PubMed ID: 36248809 [TBL] [Abstract][Full Text] [Related]
7. Blocking Allergic Reaction through Targeting Surface-Bound IgE with Low-Affinity Anti-IgE Antibodies. Zhang K; Liu J; Truong T; Zukin E; Chen W; Saxon A J Immunol; 2017 May; 198(10):3823-3834. PubMed ID: 28396318 [TBL] [Abstract][Full Text] [Related]
8. CD300a is expressed on human basophils and seems to inhibit IgE/FcεRI-dependent anaphylactic degranulation. Sabato V; Verweij MM; Bridts CH; Levi-Schaffer F; Gibbs BF; De Clerck LS; Schiavino D; Ebo DG Cytometry B Clin Cytom; 2012 May; 82(3):132-8. PubMed ID: 22173928 [TBL] [Abstract][Full Text] [Related]
9. Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut. Santos AF; Du Toit G; Douiri A; Radulovic S; Stephens A; Turcanu V; Lack G J Allergy Clin Immunol; 2015 Jan; 135(1):179-86. PubMed ID: 25567046 [TBL] [Abstract][Full Text] [Related]
10. Allergen-Specific IgA Antibodies Block IgE-Mediated Activation of Mast Cells and Basophils. El Ansari YS; Kanagaratham C; Burton OT; Santos JV; Hollister BA; Lewis OL; Renz H; Oettgen HC Front Immunol; 2022; 13():881655. PubMed ID: 35865546 [TBL] [Abstract][Full Text] [Related]
12. Suppression of the basophil response to allergen during treatment with omalizumab is dependent on 2 competing factors. MacGlashan DW; Savage JH; Wood RA; Saini SS J Allergy Clin Immunol; 2012 Nov; 130(5):1130-1135.e5. PubMed ID: 22800400 [TBL] [Abstract][Full Text] [Related]
13. Activated steady status and distinctive FcεRI-mediated responsiveness in basophils of atopic dermatitis. Imamura S; Washio K; Mizuno M; Oda Y; Fukunaga A; Nishigori C Allergol Int; 2021 Jul; 70(3):327-334. PubMed ID: 33674191 [TBL] [Abstract][Full Text] [Related]
14. Optimizing of the basophil activation test: Comparison of different basophil identification markers. Eberlein B; Hann R; Eyerich S; Pennino D; Ring J; Schmidt-Weber CB; Buters J Cytometry B Clin Cytom; 2015; 88(3):183-9. PubMed ID: 25399741 [TBL] [Abstract][Full Text] [Related]
19. Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy. Patil SU; Steinbrecher J; Calatroni A; Smith N; Ma A; Ruiter B; Virkud Y; Schneider M; Shreffler WG J Allergy Clin Immunol; 2019 Nov; 144(5):1310-1319.e4. PubMed ID: 31377342 [TBL] [Abstract][Full Text] [Related]
20. A comparative study on basophil activation test, histamine release assay, and passive sensitization histamine release assay in the diagnosis of peanut allergy. Larsen LF; Juel-Berg N; Hansen KS; Clare Mills EN; van Ree R; Poulsen LK; Jensen BM Allergy; 2018 Jan; 73(1):137-144. PubMed ID: 28686296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]